Asthma and Allergy Research Associates

Upland, Pennsylvania 19013

0 studies enrolling now · 9 studies all time

What they study most

Allergic Rhinitis, Asthma, PAR, Perennial Allergic Rhinitis, Seasonal Allergic Rhinitis, Type I Hypersensitivity

Studies at this site

• A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication — Completed
• Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies — Completed
• A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma — Completed
• A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR) — Completed
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR) — Completed
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR). — Completed
• A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older — Completed
• Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen — Completed
• Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen — Completed